ImmunoGen, Waltham, Mass., has hired Dr. Charles Morris as executive VP and chief development officer.
Morris, whose age wasn't provided, is the former executive VP and chief medical officer at Allos Therapeutics, the Westminster, Colo.-based biotech company that was purchased this year by Henderson, Nev.-based Spectrum Pharmaceuticals. ImmunoGen develops anti-cancer therapeutics. Morris' employment is effective immediately.
“Charlie has extensive experience leading the strategic development and registration of novel oncology compounds—expertise essential to ImmunoGen with our advancing and expanding product pipeline,” ImmunoGen President and CEO Daniel Junius said in a news release.
“We now have three wholly owned clinical-stage compounds, expect to advance our fourth product candidate into the clinic in 2013, and have additional highly promising compounds behind these in our pipeline. We are excited to have Charlie joining ImmunoGen at this important time in our transition to being a product development company.”